1. Home
  2. FATE vs GHG Comparison

FATE vs GHG Comparison

Compare FATE & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.58

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.09

Market Cap

116.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
FATE
GHG
Founded
2007
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
116.0M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
FATE
GHG
Price
$2.58
$1.09
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
1.9M
6.3K
Earning Date
05-14-2026
04-29-2026
Dividend Yield
N/A
4.15%
EPS Growth
29.88
N/A
EPS
N/A
N/A
Revenue
$6,646,000.00
N/A
Revenue This Year
N/A
$19.02
Revenue Next Year
N/A
$8.26
P/E Ratio
N/A
$5.76
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$1.09
52 Week High
$3.23
$2.57

Technical Indicators

Market Signals
Indicator
FATE
GHG
Relative Strength Index (RSI) 48.53 43.37
Support Level $1.01 $1.10
Resistance Level $2.88 $1.16
Average True Range (ATR) 0.19 0.02
MACD -0.00 -0.00
Stochastic Oscillator 48.41 28.57

Price Performance

Historical Comparison
FATE
GHG

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: